Nanobody targeting glycan cap confers broad orthoebolavirus neutralization. [PDF]
Zhang X +10 more
europepmc +1 more source
Public Information Demand During the 2026 Bundibugyo Virus Outbreak: A Dual Infodemiology Analysis Across Six Ebola Virus Disease Outbreaks. [PDF]
Öztürk H, Aylı BI.
europepmc +1 more source
Detection of Marburg Virus Antibodies 25 Years After Outbreak in Watsa, Democratic Republic of the Congo. [PDF]
Merritt S +15 more
europepmc +1 more source
Whole-Genome Sequencing for High-Consequence Emerging RNA Viruses: Strategy Selection for Bundibugyo Virus Disease Under 2026 Outbreak Constraints. [PDF]
Kopp K.
europepmc +1 more source
Serological evidence of zoonotic filovirus exposure among bushmeat hunters in Guinea. [PDF]
Akoi Boré J +18 more
europepmc +1 more source
Mapping the global evidence base of bundibugyo ebolavirus disease: a systematic scoping review of research gaps and preparedness priorities. [PDF]
Boatemaa A, Osei B, Forkuo GO.
europepmc +1 more source
A highly potent nanobody-based bispecific therapeutic provides broad-spectrum protection against ebolavirus. [PDF]
Wang M +22 more
europepmc +1 more source
Filovirus vaccines as a response paradigm for emerging infectious diseases. [PDF]
Marzi A, Feldmann H.
europepmc +1 more source
Effectiveness of a Teaching Program on Ebola Virus Knowledge Among Nursing Students. [PDF]
Ghorpade VK, Geddugol BJ.
europepmc +1 more source

